SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(3)
ARTICLES/BLOGS
2022(8)
2021(7)
2020(4)
2019(15)
2018(7)
2017(14)
2016(14)
2015(15)
2014(1)
CATEGORIES
5-Minute Market Rundown(4)
Analyst Update(12)
Analyst Upgrades(3)
Buzz Stocks(33)
By the Numbers(2)
Earnings Preview(3)
Ezines(2)
General(5)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(10)
Technical Analysis(1)
The Week Ahead(1)

11/28/2022 9:37 AM
Biogen Inc (NASDAQ:BIIB) is under pressure this morning, in the wake of a research paper published on Science.org this Sunday. The report indicated a 65-year-old patient receiving the experimental Al...
11/21/2022 10:49 AM
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is down 2.1% at $8.54 at last check, after the company named former Novartis (NVS) and Biogen (BIIB) executive Richard Francis as its new chief execu...
11/14/2022 10:57 AM
While several sectors are taking a breather this morning, Biogen Inc (NASDAQ:BIIB) is climbing after major competitor Roche (ROG) said that its Alzheimer's drug candidate, gantenerumab, failed to me...
9/28/2022 9:16 AM
The shares of Biogen Inc (NASDAQ:BIIB) are seeing an unprecedented surge ahead of the open, last seen up 53.2% at $302.91 after announcing that the experimental Alzheimer's drug it developed in conju...
7/20/2022 10:21 AM
Biogen Inc (NASDAQ: BIIB ) earlier lifted its full-year profit forecast after reporting blowout second-quarter profits of $5.25 per share on revenue of $2.59 billion, both of which came in above Wall...